REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Bioasep Cia.Ltda (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Bioasep Cia.Ltda Profile Updated: February 10, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Bioasep Cia.Ltda is an enterprise located in Ecuador, with the main office in Quito. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on March 27, 2017. It currently has a total number of 11 (2024) employees. From the latest financial highlights, Bioasep Cia.Ltda reported a net sales revenue increase of 17.62% in 2024. Its’ total assets recorded a negative growth of 6.96%. In 2024, Bioasep Cia.Ltda’s net profit margin decreased by 28.19%.

Headquarters
Juan Vallauri E1-61
Quito; Pichincha;

Contact Details: Purchase the Bioasep Cia.Ltda report to view the information.

Website: http://www.bioasepeg.net

Basic Information
Total Employees:
Purchase the Bioasep Cia.Ltda report to view the information.
Registered Capital:
Purchase the Bioasep Cia.Ltda report to view the information.
Financial Auditors:
Purchase the Bioasep Cia.Ltda report to view the information.
Incorporation Date:
March 27, 2017
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
49%
Company Performance
Financial values in the chart are available after Bioasep Cia.Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
17.62%▲
Total operating revenue
14.56%▲
Operating profit (EBIT)
-36.23%▼
EBITDA
-33.32%▼
Net Profit (Loss) for the Period
-58.91%▼
Total assets
-6.96%▼
Total equity
-30.76%▼
Operating Profit Margin (ROS)
-21.88%▼
Net Profit Margin
-28.19%▼
Return on Equity (ROE)
-23.2%▼
Debt to Equity Ratio
-4.63%▼
Quick Ratio
-2.02%▼
Cash Ratio
-1.08%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo